| Literature DB >> 34136036 |
Liping Zeng1, Runzhou Zhuang1, Zhengliang Tu1.
Abstract
INTRODUCTION: Video-assisted thoracic surgery (VATS) has been widely accepted in the diagnosis and treatment of thoracic diseases for the past three decades due to its small incision, minimal trauma, and rapid recovery after surgery. A growing number of patients with concurrent pulmonary nodules and mediastinal lesions have been detected. Simultaneous ipsilateral resection of coexisting lesions is a preferred procedure. AIM: To introduce our technique and preliminary experience in performing uniportal video-assisted thoracic surgery (VATS) for the simultaneous resection of pulmonary and mediastinal lesions.Entities:
Keywords: mediastinal lesion; pulmonary nodule; simultaneous resection; uniportal video-assisted thoracic surgery
Year: 2020 PMID: 34136036 PMCID: PMC8193751 DOI: 10.5114/wiitm.2020.101240
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Photo 1A – The patient was placed in the lateral decubitus position. B – The operating room setup and positions of the surgeon and the first assistant for resection of the pulmonary nodule
Photo 2A – The patient was adjusted to an approximately 45° semi-supine position by rolling the operating table. B – The operating room setup and positions of the surgeon and the first assistant for resection of the mediastinal lesion
Patient demographics and clinical characteristics
| No. | Gender | Age | Pulmonary nodule | Mediastinal lesion | ||
|---|---|---|---|---|---|---|
| Location (number of the nodule) | Size [cm] | Location | Size [cm] | |||
| 1 | Female | 63 | RLL (1) | 1.5 | Anterior | 3 |
| 2 | Male | 71 | RS8 (1), RS6 (1), RS2 (2) | 1.5, 0.8, 0.6, 0.5 | Anterior | 2.4 |
| 3 | Female | 55 | Left lungs (disseminated) | Range: 2–4 mm | Anterior | 7 |
| 4 | Female | 47 | RUL (1), RLL (1) | 0.5, 0.7 | Anterior | 2.2 |
| 5 | Female | 51 | RS6 (1) | 0.8 | Anterior | 1 |
| 6 | Female | 67 | RML (2) | 0.5, 0.3 | Anterior | 1.8 |
| 7 | Male | 45 | LUL (1) | 0.5 | Anterior | 1.9 |
| 8 | Male | 65 | RUL (3) | 0.9, 0.5, 0.4 | Anterior | 3.3 |
RLL – right upper lobe, RS8 – the anterior basal segment of the right lower lobe, RS6 – the apical segment of the right lower lobe, RS2 – the posterior segment of the right upper lobe, RUL – right upper lobe, RML – right middle lobe, LUL – left upper lobe.
Surgical details
| No. | Patients’ position | Intercostal incision | Incision length [cm] | Operation method | Operation time [min] | Operative bleeding [ml] | Postoperative thoracic drainage time [days] | Postoperative thoracic drainage volume [ml] | Complication | Postoperative hospital stay [days] |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1: Lateral decubitus position | The 4th ICS | 4 | Uniportal VATS lobectomy (RLL) and mediastinal lymph node dissection + total thymectomy | 161 | 50 | 9 | 1245 | Prolonged air leak | 9 |
| 2 | 1: Lateral decubitus position | The 4th ICS | 4 | Uniportal VATS segmentectomy (RS8) and wedge resection (RS6) and wedge resection (RS2) and mediastinal lymph node dissection + limited thymectomy | 208 | 50 | 3 | 600 | / | 4 |
| 3 | Lateral decubitus position | The 4th ICS | 4 | Uniportal VATS wedge resection (LLL, left lower lobe) + limited thymectomy | 65 | 20 | 2 | 140 | / | 3 |
| 4 | 1: Lateral decubitus position | The 4th ICS | 4 | Uniportal VATS wedge resection (RUL) and wedge resection (RLL) + cyst excision | 57 | 10 | 2 | 360 | / | 3 |
| 5 | 1: Lateral decubitus position | The 4th ICS | 4 | Uniportal VATS segmentectomy (RS6) and mediastinal lymph node sampling + limited thymectomy | 109 | 50 | 2 | 320 | / | 4 |
| 6 | 1: Lateral decubitus position | The 4th ICS | 4 | Uniportal VATS wedge resection (RML) and mediastinal lymph node sampling + limited thymectomy | 59 | 10 | 2 | 100 | / | 3 |
| 7 | Lateral decubitus position | The 4th ICS | 3 | Uniportal VATS wedge resection (LUL) + cyst excision | 43 | 10 | 2 | 60 | / | 3 |
| 8 | 1: Lateral decubitus position | The 4th ICS | 4 | Uniportal VATS lobectomy (RUL) and mediastinal lymph node sampling + cyst excision | 116 | 20 | 2 | 300 | / | 3 |
| Average | / | / | 3.9 ±0.3 | / | 102.3 ±54.4 | 27.5 ±17.9 | 3.0 ±2.3 | 390.6 ±361.3 | 4.0 ±1.9 |
Pathology and follow-up
| No. | Pathological diagnosis | Follow-up [months] | Status | |
|---|---|---|---|---|
| Pulmonary nodule | Mediastinal lesion | |||
| 1 | Invasive adenocarcinoma (IA, T1bN0M0) | Thymoma (B2, Masaoka II) | 20 | Alive |
| 2 | Nodule1 (RS8): invasive adenocarcinoma, IA, T1bN0M0, Nodule2 (RS2): adenocarcinoma | Bronchogenic cyst | 19 | Alive |
| 3 | Metastatic B-cell lymphoblastic lymphoma | B-cell lymphoblastic lymphoma | 16 | Alive |
| 4 | Nodule1 (RUL): chronic pulmonary inflammation, Nodule2 (RLL): chronic pulmonary inflammation | Thymic cyst | 16 | Alive |
| 5 | Invasive adenocarcinoma (IA, T1aN0M0) | Bronchogenic cyst | 13 | Alive |
| 6 | Nodule1 (RML): minimally invasive adenocarcinoma, IA, T1aN0M0, Nodule2 (RML): minimally invasive adenocarcinoma, IA, T1aN0M0 | Bronchogenic cyst | 13 | Alive |
| 7 | Pulmonary collagenous nodule | Bronchogenic cyst | 13 | Alive |
| 8 | Nodule1 (RUL): invasive adenocarcinoma, IA, T1aN0M0, Nodule2 (RUL): adenocarcinoma | Thymic cyst | 13 | Alive |